Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 517

Similar articles for PubMed (Select 15705013)

1.

Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.

Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, Moore H.

J Clin Psychiatry. 2005 Feb;66(2):253-9.

PMID:
15705013
2.

Exercise outcomes in prevalent users of stimulant medications.

Westover AN, Nakonezny PA, Barlow CE, Vongpatanasin W, Adinoff B, Brown ES, Mortensen EM, Halm EA, DeFina LF.

J Psychiatr Res. 2015 May;64:32-9. doi: 10.1016/j.jpsychires.2015.03.011. Epub 2015 Mar 21.

PMID:
25840827
3.

Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?

Hammerness PG, Karampahtsis C, Babalola R, Alexander ME.

Expert Opin Drug Saf. 2015 Apr;14(4):543-51. doi: 10.1517/14740338.2015.1011620. Epub 2015 Feb 3.

PMID:
25648243
4.

Bupropion in adults with Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind study.

Hamedi M, Mohammdi M, Ghaleiha A, Keshavarzi Z, Jafarnia M, Keramatfar R, Alikhani R, Ehyaii A, Akhondzadeh S.

Acta Med Iran. 2014;52(9):675-80.

5.

Blood Pressure, Heart Rate, and CNS Stimulant Medication Use in Children with and without ADHD: Analysis of NHANES Data.

Hailpern SM, Egan BM, Lewis KD, Wagner C, Shattat GF, Al Qaoud DI, Shatat IF.

Front Pediatr. 2014 Sep 19;2:100. doi: 10.3389/fped.2014.00100. eCollection 2014.

6.

Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update.

Awudu GA, Besag FM.

Drug Saf. 2014 Sep;37(9):661-76. doi: 10.1007/s40264-014-0201-8. Review.

PMID:
25124483
7.

Cardiac autonomic dysfunction and arterial stiffness among children and adolescents with attention deficit hyperactivity disorder treated with stimulants.

Kelly AS, Rudser KD, Dengel DR, Kaufman CL, Reiff MI, Norris AL, Metzig AM, Steinberger J.

J Pediatr. 2014 Oct;165(4):755-9. doi: 10.1016/j.jpeds.2014.05.043. Epub 2014 Jul 9.

PMID:
25015574
8.

ADHD and pregnancy.

Freeman MP.

Am J Psychiatry. 2014 Jul;171(7):723-8. doi: 10.1176/appi.ajp.2013.13050680.

PMID:
24980168
9.

Food and drug administration regulation of drugs that raise blood pressure.

Blankfield RP, Iftikhar IH.

J Cardiovasc Pharmacol Ther. 2015 Jan;20(1):5-8. doi: 10.1177/1074248414531852. Epub 2014 May 6.

PMID:
24803642
10.

Addressing the problem of ADHD medication as neuroenhancements.

Graf WD, Miller G, Nagel SK.

Expert Rev Neurother. 2014 May;14(5):569-81. doi: 10.1586/14737175.2014.908707. Epub 2014 Apr 17. Review.

PMID:
24738763
11.

Psychopharmacological treatment of ADHD in adults aged 50+: an empirical study.

Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S.

J Atten Disord. 2015 May;19(5):380-9. doi: 10.1177/1087054714527342. Epub 2014 Mar 29.

PMID:
24681898
12.

ADHD: monitoring for and managing stimulant adverse effects.

Mercer M, Farver D.

S D Med. 2013 Dec;66(12):511, 513. No abstract available.

PMID:
24527549
13.

[Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].

Bange F, Le Heuzey MF, Acquaviva E, Delorme R, Mouren MC.

Arch Pediatr. 2014 Jan;21(1):108-12. doi: 10.1016/j.arcped.2013.11.001. Epub 2013 Dec 3. French.

PMID:
24309201
14.

A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD).

Sharma A, Couture J.

Ann Pharmacother. 2014 Feb;48(2):209-25. doi: 10.1177/1060028013510699. Epub 2013 Nov 1. Review.

PMID:
24259638
15.

Prolactinoma-associated obesity treated with bupropion and methylphenidate.

Terock J, Hohagen F, Petersen D, Zurowski B.

Ther Adv Psychopharmacol. 2013 Jun;3(3):177-80. doi: 10.1177/2045125312467345. No abstract available.

16.

Attention deficit hyperactivity disorder screening electrocardiograms: a community-based perspective.

Shahani SA, Evans WN, Mayman GA, Thomas VC.

Pediatr Cardiol. 2014 Mar;35(3):485-9. doi: 10.1007/s00246-013-0810-5. Epub 2013 Oct 19.

PMID:
24141829
17.

Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies.

Spencer TJ, Brown A, Seidman LJ, Valera EM, Makris N, Lomedico A, Faraone SV, Biederman J.

J Clin Psychiatry. 2013 Sep;74(9):902-17. doi: 10.4088/JCP.12r08287. Review.

18.

Attention-deficit/hyperactivity disorder stimulant medication reaction masquerading as chronic cough.

Leibel S, Bloomberg G.

Ann Allergy Asthma Immunol. 2013 Aug;111(2):82-3. doi: 10.1016/j.anai.2013.05.016. Epub 2013 Jun 19. No abstract available.

PMID:
23886223
19.

Effects of caffeinated versus decaffeinated energy shots on blood pressure and heart rate in healthy young volunteers.

Kurtz AM, Leong J, Anand M, Dargush AE, Shah SA.

Pharmacotherapy. 2013 Aug;33(8):779-86. doi: 10.1002/phar.1296. Epub 2013 May 30.

PMID:
23722481
20.

Attention-deficit/hyperactivity disorder, physical health, and lifestyle in older adults.

Semeijn EJ, Kooij JJ, Comijs HC, Michielsen M, Deeg DJ, Beekman AT.

J Am Geriatr Soc. 2013 Jun;61(6):882-7. doi: 10.1111/jgs.12261. Epub 2013 May 27.

PMID:
23711084
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk